RankingsPricing
  1. JP-listed companies
  2. NANO MRNA Co.,Ltd.
  3. Financials
  4. Common stock and paid-in capital

NANO MRNA Co.,Ltd.【JP:4571】

Market cap
¥10.3B
P/E ratio
-9.9x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndCommon stock and paid-in capital (Million JPY)YoY (%)
Mar 31, 20255,713+0.84%
Mar 31, 20245,665+0.83%
Mar 31, 20235,619-45.44%
Mar 31, 202210,298+0.37%
Mar 31, 202110,260-18.01%
Mar 31, 202012,514+57.80%
Mar 31, 20197,931-64.25%
Mar 31, 201822,184+0.15%
Mar 31, 201722,151+2.88%
Mar 31, 201621,531+0.06%
Mar 31, 201521,518

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)